Gefitinib effect on various non-small cell lung cancer cell lines (HG-U133A)

Download

Analysis of baseline non-small cell lung cancer (NSCLC) cell lines with a broad range of sensitivity to the anticancer drug gefitinib. Gefitinib is an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI). Results used to define a gene expression signature of gefitinib sensitivity.

Cancer Type: Lung Cancer

GPL: 96

Number of Genes with Data: 939

Number Observations: 45

Number Outputs: 1

Imbalanced Ratio: 0.323529412

Default Task: Classification